Observational Study to Assess the Incidence Rate of the Major Adverse Cardiovascular Events (MACE) and Safety of Fenofibrate (Lipilfen Capsule)
NCT02069717 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2016-10-26
Summary
The purpose of this study was to assess the incidence rate of the major adverse cardiovascular events (MACE) and safety of fenofibrate (Lipilfen capsule) add-on statin therapy in patients who have history of acute myocardial infarction and are diagnosed with metabolic syndrome.
Conditions
- Metabolic Syndrome
Interventions
- OTHER
-
Not applicable-observational study
Sponsors & Collaborators
-
Daewoong Pharmaceutical Co. LTD.
lead INDUSTRY
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-10-31
- Primary Completion
- 2014-09-30
- Completion
- 2014-09-30
Countries
- South Korea
Study Locations
More Related Trials
-
Pitavastatin on Carotid Intima-media Thickness
NCT00711919 ·Status: UNKNOWN ·Phase: NA
-
Impact of Pitavastatin in Hypercholesterolemic Patients With Metabolic Syndrome
NCT00444717 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Pitavastatin on Monocyte, Endothelial Dysfunction and HDL-C in Subjects With Metabolic Syndrome
NCT01595828 ·Status: COMPLETED ·Phase: PHASE1
-
Aspirin Mono Therapy 12-months After Drug-eluting Stents Implantation
NCT01557075 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluate the Efficacy of Fenofibrate on Microalbuminuria
NCT02314533 ·Status: UNKNOWN ·Phase: PHASE4
-
Effects of Pitavastatin Treatments on the Plasma Lgi3 Level in the Patients With Dyslipidemia
NCT03730038 ·Status: COMPLETED ·Phase: NA
-
Effect of Acute Statin Treatment in Patients Undergoing Percutaneous Coronary Intervention
NCT00588471 ·Status: TERMINATED ·Phase: NA
-
Progression of Sub-Clinical Atherosclerosis
NCT00241787 ·Status: COMPLETED
-
Rapid Escalation of LipiD Lowering Therapy to Reduce RecUrrent Cardiovascular Event
NCT07311941 ·Status: RECRUITING
-
Effect of a Decision Aid About Statin Use in Patients With Type 2 Diabetes Mellitus
NCT00217061 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Patients With Statin Myopathy Using an N of 1 Trial Design
NCT01259791 ·Status: COMPLETED ·Phase: NA
-
Prospective Observational Study of Pravafenix Cap
NCT03214211 ·Status: UNKNOWN
-
An Observational Study of Statin Treatment Induced HDL Changes
NCT01551784 ·Status: COMPLETED
-
Endothelial Dysfunction in Subjects With History of Premature Coronary Artery Disease
NCT00917527 ·Status: UNKNOWN ·Phase: PHASE4
-
The Acute Effect of Statins on Inflammatory Markers of Athersclerotic Tissue
NCT00587717 ·Status: COMPLETED ·Phase: NA
-
Effects of Short-term Intensive Statin Therapy on Lipid Levels
NCT07344610 ·Status: RECRUITING
-
Hepatic Safety of Statin Use in Neurology Inpatients
NCT06592196 ·Status: RECRUITING
-
Efficacy and Safety of Pitavastatin in a Real-world Setting
NCT04402112 ·Status: COMPLETED
-
The Role of Atorvastatin on Monocyte Function in Patients With Coronary Artery Disease and Hypercholesterolemia
NCT00329069 ·Status: COMPLETED ·Phase: NA
-
Further Lipid-Lowering With PCSK9 Inhibitors for Cardiovascular Outcomes in High-Risk Coronary Plaques Assessed by CT Angiography
NCT06863545 ·Status: RECRUITING ·Phase: NA
-
Single Dose PCSK9 Inhibitor to Improve Cardiovascular Outcomes After PCI: A Pilot Study
NCT07084259 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Yokohama Assessment of Fluvastatin, Pravastatin, Pitavastatin and Atorvastatin in Acute Coronary Syndrome (Yokohama-ACS)
NCT00549926 ·Status: COMPLETED ·Phase: PHASE4
-
Statins and Risk of Myocardial Infarction in Real Life in France
NCT00679575 ·Status: COMPLETED
-
Observational Prospective Study OPTIMA II - Follow-up
NCT02099565 ·Status: COMPLETED
-
Lipid-lowering Therapy for Secondary Prevention in Patients Undergoing Elective Percutaneous Coronary Intervention (PCI)
NCT01190072 ·Status: TERMINATED